Immuron Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:IMCHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (19.82%)
Div yield —
ROE (38.27%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (56.79%)
Mkt cap A$11.30M
ROIC (22.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.042
19.95%
99.60%
Hold 4|10|1|0|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
6.68%
12.37%
27.00%
25.73%
Revenue$M
0.530
0.525
0.553
0.540
2.94%
(1.94%)
2.28%
0.41%
Peers (US$7.761M)
Cap (US$)
PE
8.031M
—
Capital
TTM
5Y
10Y
Leveragex
0.536
—
(0.011)
EBIT/Intx
2.739
0.150
0.143
Own earn%
84.16
(99.59)
(103.54)
Sh yield%
33.38
48.61
46.10
Owners
Insiders/Inst%
0.67
31.76
Short interest%
4.76
SBC / revenue%
5.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
10